Status:
UNKNOWN
EndoRings Colonoscopy for Adenoma Detection
Lead Sponsor:
Helios Albert-Schweitzer-Klinik Northeim
Conditions:
Adenoma
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
Adenoma detection rate (ADR) in colon cancer screening is most important for avoiding colon cancer development. Recent studies suggest a benefit of endoscopic devices attached to the distal tip of the...
Eligibility Criteria
Inclusion
- indication for colonoscopy (screening, surveillance, diagnostic)
- age ≥ 45 years
- ability to give informed consent
Exclusion
- pregnancy
- age \<45 years
- known colonic strictures
- chronic inflammatory bowel disease
- active inflammation
- s/p colonic resection
- bleeding disorder
Key Trial Info
Start Date :
March 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT03469622
Start Date
March 27 2018
End Date
December 31 2019
Last Update
February 12 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
HELIOS HSK Kliniken
Wiesbaden, Hesse, Germany, 65199
2
Department of Gastroenterology, University Medical Center
Göttingen, Lower Saxony, Germany, 37075
3
HELIOS St. Marienberg Klinik Helmstedt
Helmstedt, Germany
4
Helios Albert-Schweitzer-Hospital, Academic University Teaching Hospital
Northeim, Germany, 37154